2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Multiple Sclerosis
2
Carcinoma in Situ
2
Sarcoma, Kaposi
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis, Chronic Progressive
1
HIV Infections
1
Acquired Immunodeficiency Syndrome
1
Interventions
teriflunomide
1
Vitamin D
1
Natalizumab
1
Interferon beta-1b
1
Fingolimod Hydrochloride
1
Dimethyl Fumarate
1
Cholecalciferol
1
Calcifediol
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Sclerosis, Relapsing-Remitting
×
Interferon beta-1b
×
Clear all
NCT03134573
2019-03-26
PROmyBETAapp
Bayer
Completed
96 enrolled